University of Texas MD describes symptoms, treatment, and prognosis for patients suffering with this rare but severe lysosomal disorder.

Medical professionals can access resources on this enzyme-replacement therapy for Fabry's disease. Product is approved for use in the European Union only.

German-based organization with news updates, relevant links, and addresses of research centers and support groups. Includes German language site.